Comparative #RWE on smoking-cessation therapies is limited, especially for economic outcomes. This study utilized US national claims databases to compare smoking-attributable and all-cause costs of two therapies: https://t.co/yUkZPPssTn https://t.co/GPYE6W
RT @Dick_Puddlecote: Pfizer-funded study finds that its most profitable product is really good, cue total silence from 'public health' who…
Can’t be denied, double-standards here
RT @Dick_Puddlecote: Pfizer-funded study finds that its most profitable product is really good, cue total silence from 'public health' who…